Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Tencent Music
TME
$14.2B
| $11.3M | 0.01% |
1,555,340
+606,668
| +64% | +$5.95M |
|
|
PLMIU
1877
DELISTED
Plum Acquisition Corp. I Units
PLMIU
| $11.3M | 0.01% |
1,149,431
+1,715
| +0.1% | +$17K |
|
1878
Northern Oil and Gas
NOG
$2.78B
| $11.3M | 0.01% |
526,466
+152,568
| +41% | +$2.67M |
|
1879
VeriSign
VRSN
$26.6B
| $11.3M | 0.01% |
54,917
+16,496
| +43% | +$3.61M |
|
1880
Wingstop
WING
$3B
| $11.2M | 0.01% |
68,346
-7,100
| -9% | -$1.2M |
|
|
ZTAQU
1881
DELISTED
Zimmer Energy Transition Acquisition Corp. Units
ZTAQU
| $11.2M | 0.01% |
1,124,764
+4,699
| +0.4% | +$47.2K |
|
1882
ZIM Integrated Shipping Services
ZIM
$3.36B
| $11.2M | 0.01% |
220,606
+4,388
| +2% | +$205K |
|
|
VMRK
1883
CALL
Vivmark Residential
VMRK
$26.1B
| $11.2M | 0.01% |
138,200
+102,100
| +283% | +$8.43M |
|
1884
Magnite
MGNI
$3.35B
| $11.2M | 0.01% |
399,085
-250,972
| -39% | -$7.55M |
|
|
NSTD
1885
DELISTED
Northern Star Investment Corp. IV
NSTD
| $11.2M | 0.01% |
1,139,268
+856,632
| +303% | +$8.34M |
|
1886
OceanFirst Financial
OCFC
$1.83B
| $11.2M | 0.01% |
521,072
-49,157
| -9% | -$1.01M |
|
1887
iShares MSCI EAFE ETF
EFA
$79.8B
| $11.1M | 0.01% |
142,851
+56,852
| +66% | +$4.55M |
|
1888
Supernus Pharmaceuticals
SUPN
$2.57B
| $11.1M | 0.01% |
417,524
+312,679
| +298% | +$8.39M |
|
1889
Hancock Whitney
HWC
$6.02B
| $11.1M | 0.01% |
235,996
+114,320
| +94% | +$5.07M |
|
1890
BridgeBio Pharma
BBIO
$15.4B
| $11.1M | 0.01% |
237,215
+96,204
| +68% | +$5.16M |
|
|
FMBI
1891
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $11.1M | 0.01% |
584,742
+540,346
| +1,217% | +$9.95M |
|
1892
Cavco Industries
CVCO
$4.39B
| $11.1M | 0.01% |
46,939
+33,197
| +242% | +$7.98M |
|
1893
PUT
Danaher
DHR
$152B
| $11.1M | 0.01% |
41,172
-3,948
| -9% | -$1.07M |
|
1894
CALL
Philips
PHG
$26.3B
| $11.1M | 0.01% |
302,655
-60,532
| -17% | -$2.3M |
|
1895
Rigetti Computing
RGTI
$5.49B
| $11.1M | 0.01% |
1,142,357
+453,080
| +66% | +$4.41M |
|
|
TSP
1896
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $11.1M | 0.01% |
299,006
+288,985
| +2,884% | +$12.2M |
|
|
LKFT
1897
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $11.1M | 0.01% |
210,645
+64,696
| +44% | +$3.84M |
|
1898
PUT
HP
HPQ
$27.1B
| $11.1M | 0.01% |
404,800
+44,900
| +12% | +$1.29M |
|
1899
CALL
United Therapeutics
UTHR
$22.6B
| $11.1M | 0.01% |
+60,000
| New | +$11.8M |
|
|
ZH
1900
Zhihu
ZH
$261M
| $11.1M | 0.01% |
199,733
+103,543
| +108% | +$6.22M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.